Food and beverage testing is a critical scientific practice that ensures food safety, food quality, and compliance of food and drink products. Through comprehensive analysis, food testing labs assess factors such as microbiological contamination, chemical residues, nutritional content, and authenticity. By adhering to strict regulatory standards and industry guidelines, food and beverage testing helps maintain product integrity, fight food fraud, prevent foodborne illnesses, and meet consumer expectations for safety and transparency. Explore how food and beverage testing labs play a pivotal role in safeguarding public health and promoting trust in the global food supply chain.
Technical Advantage: Effective against Gram-positive and -negative Bacteria, and mycoplasma Gentamicin works as an antimicrobial agent by binding to the 30S ribosomal subunit of certain bacteria. It is formulated to contain 50 mg/ml gentamicin in deionized water and is recommended for use in cell culture applications at 1 ml/L. This product is effective against mycoplasma, Gram-negative and Gram-positive bacteria and is st…
Corning® BioCoat™12mm #1 German Glass Coverslip with a uniform application of Poly-D-Lysine. Bulk packed, 80/case. Corning BioCoat products are an ideal solution for enhanced cell attachment and growth of a variety of primary cells and transformed cells in serum-free or serum-containing cultures. Corning offers custom coating capabilities. Shelf life: >= 3 months from date of shipment.
Corning CoolCell, in combination with a -80°C freezer, will provide alcohol-free freezing at the rate of -1°C/minute that is ideal for cryopreservation of most cells and cell lines. Using a combination of uniform-density cross-linked polyethylene foam, a solid state core, and radial vial symmetry, freezing profiles are consistent and reproducible. The foam is non-absorbent and will impose negligible change in the freezer envir…
5 mL capacity with round bottomSelf-standing designManufactured from polypropylene to withstand temperatures to -196°CSilicone washer for a secure sealVials may be color coded with inserts (see Cat. No. 430499)Special base design allows vials to be locked into cryogenic rack and tray (Cat. No. 431131) for single-handed manipulationSterilized by gamma radiationNonpyrogenic and DNase/RNase-free
Designed to meet the everyday challenges facing pharmaceutical quality control (QC) labs, the Alliance™ iS HPLC System delivers a new era of intuitive simplicity by reducing errors with innovative system intelligence, enhancing productivity with safeguards to ensure system performance, and maximizing system uptime.
An expanding portfolio of NGS panels for research into haematological and solid tumour cancers, as well as library preparation kits for the accurate detection of a wide range of genetic aberrations
The SureSeq™ Myeloid Plus NGS Complete Workflow combines the rapid Universal NGS Workflow hybridisation-based target enrichment method together with OGT’s expert bait design to detect 49 key genes implicated in myeloid disorders.
The SureSeq™ CLL + CNV Panel has been designed in collaboration with recognised cancer experts to detect 13 key genes and 5 chromosomal regions implicated in CLL progression (Table 1). The SureSeq CLL + CNV Panel alleviates the burden of running multiple assays and streamlines your CLL research to deliver a comprehensive genomic profile for each CLL sample using a single workflow
Myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characterised by the overproduction of one or more types of blood cells. The SureSeq™ Core MPN Panel has been designed in collaboration with recognised cancer experts to detect somatic variants in 3 clinically relevant MPN associated genes; JAK2, MPL and CALR.
The complete library preparation solution for unparalleled next generation sequencing (NGS) results. Based on scientists’ feedback, we have redesigned our workflow to ensure scientists achieve the most optimal NGS libraries, with one library preparation workflow across both our SureSeq™ and CytoSure® Constitutional NGS products.
Interpret is OGT’s powerful and easy-to-use next-generation sequencing analysis solution.
Certified reference material, Trace CERT ® , 100 μg/mL each component in methanol, ampule of 1 mL.
Hipersep® Prochrom columns have been designed to run for decades without any loss of performance. This performance consistency over time is enabled by Dynamic Axial Compression (DAC) technology. Our columns are engineered for ease of cleaning and maintenance operations while maximizing operator safety.
LiquidPlex panel is an advanced and user-friendly research assay for targeted next generation sequencing of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly associated with solid tumor type cancers.
FusionPlex Lung v2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 17 genes associated with NSCLC.
FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.
FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.
FusionPlex Pan Solid V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 137 genes associated with various solid tumor malignancies.
VariantPlex Solid Tumor Focus V2 is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 20 genes associated with various solid tumor malignancies.
VariantPlex Core Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 60 genes associated with various solid tumor malignancies.
VariantPlex Expanded Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 76 genes associated with various solid tumor malignancies.
VariantPlex Pan Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 185 genes associated with various solid tumor malignancies.
VariantPlex Complete Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 430 genes associated with various solid tumor malignancies.
Immunoverse is a research assay that characterizes the immune repertoire, including assessment of T- and B-cell clonalities and rare clones, and detection of tumor infiltrating lymphocytes (TIL) and somatic hypermutation with targeted NGS of key T cell receptor and B cell receptor chain RNA relevant for blood cancer and solid tumor research.
VariantPlex Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 75 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).
